
W
EIGHT AND crown-rump LENGTH REDUCTION, GROSS MALFORMATION AND PREGNANCY OUTCOME IN CARTHAMUS TINCTORIUS L-TREATED MICESoghra Bahmanpour PhD*, Katayoun Javidnia PhD**
, Hesum Arandi PharmD**
*Department of Anatomy, School of Medicine, **Department of Medical Chemistry, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
Correspondence: K. Javidnia PhD, Department of Medical Chemistry, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran. P. O. Box: 71345-1149, E-mail: javidniak@sums.ac.ir.
The flowers of the plant Carthamus tinctorius L are used to provide color and flavor in the food industry. They are cheaper than saffron and therefore a water extract of these flowers is used instead of saffron. C. tinctorius also initiates bleeding in delayed menstruation. Therefore, in early pregnancy when the menstrual cycle is delayed, the use of C. tinctorius flowers may lead to malformation of the embryo. This experimental study was designed to investigate probable malformations due to C. tinctorius.Background
Methods
One hundred and thirty Balb/C mice were maintained under standard laboratory conditions; then two females were housed with one male overnight, and successful mating was confirmed by vaginal plug. Pregnant females were divided into two groups. In the experimental group (120 mice), aqueous extract (1, 10, 25 or 50 mg/kg) was injected intraperitoneally, on the 7th or 8th day of pregnancy as a single dose or on the 9th and 10th days as multidoses. Distilled water was injected into the control group (10 mice). The pregnant mice delivered on the 18th day of pregnancy and the fetuses were examined for external malformation. Each fetus was weighed, the crown-rump length was measured, and the number of live and resorbed fetuses was recorded.Results
Water extract of C. tinctorius flowers caused death and decreased crown-rump length and weight. Congenital malformations included exencephally, spina bifida and tail and limb necrosis also were seen.Conclusion The water extract of C. tinctorius flowers has many toxic effects on early development of the embryo and its use in pregnant women must be avoided.
Keywords · Carthamus tinctorius · embryotoxicity · teratogenicity
Introduction
In many countries, the use of plants and natural products is popular as an alternative to classic medical care. Lack of information about the toxic effects of such plants allows them to be used for medical treatment. Carthamus tinctorius L, with the persian name of Golrang (safflower), belongs to the family Compositae and has been known for thousands of years. Many Compositae plants have a folk use as an abortion promoter. It is native to the Middle-East and now-adays is also widely nowadays is also widely cultivated throughout Europe and the USA.1 Its flowers are used not only in medicine, but also for flavor and color in food and as an additive in beverages.2 The plants water extract is used in dysmenorrheal conditions and as a sedative, laxative and antiinflammatory agent in traditional medicine.3 Safflower oil is a rich source of linoleic acid and unsaturated fatty acids, and can reduce serum cholestrol levels.1 The mutagenic effect of Carthami flowers has been reported in the literature,4, 5 and sterols, and erytro-alkane-6,8-diols, which have anti-inflammatory and antitumor-promoting activity, are present in Carthamus extract.6 C. tinctorius extract in doses of 0.2 2 mg/kg/day during 0 8 days of gestation induces microscopic changes in the mouse embryo that leads to histological changes in the nervous system.7 Because the reported study was limited to a specific tissue, the present study investigated morphological malformations in the whole mice embryos. The study aimed to evaluate the relationship between different doses of C. tinctorius in mice on different days of the organogenetic period and to compare the effect of extract on critical days of organogenesis.
Materials and Methods
Plant materials
The flowers were obtained from herbal medicinal stores (Herbarium No. 93, Faculty of Pharmacy, Tehran University of Medical Sciences). The water extract was obtained using the Soxellete procedure and dried on a rotatory evaporator. The extract was obtained with 39% yield.
Teratogenic effect of C. tinctorius L in pregnant mice
Young female Balb/C mice (130) were allowed to acclimatize to standard conditions (20 ± 4 ° C and 12-hour light-dark cycle) for 30 days. Two females weighing 30 35 g were then placed with one male of the same strain. Pregnancy was confirmed by the presence of vaginal plugs. The day of detection of a vaginal plug was designated Day 0. Pregnant mice were separated and placed in a different cage and were divided into control (10 mice) and experimental groups. The experimental group was further subdivided into groups of 10 based on the dose of water extract administered (1, 10, 25 or 50 mg/kg) and the day of exposure (7th, 8th, or 9th and 10th day). Each mouse in the experimental group received a single intraperitoneal (IP) dose on the 7th or 8th day or a single IP dose on the 9th and 10th days of pregnancy while the control mice received distilled water in the same manner. Pregnant females were sacrificed on Day 18 of pregnancy. Their abdominal cavities were opened and uterine horns were removed and placed in physiological saline. Embryos were rapidly dissected from the uterus and extraembryonic tissue was immersed in 10% formaldehyde solution. The number of resorbed, live and dead fetuses were recorded. The survivors were weighed and the crown-rump length was measured. Fetuses were evaluated in terms of gross malformations. For detailed studies, specimens were observed under a Zeiss stereomicroscope. Cleft palate effect was studied randomly in abnormal fetuses. Data were analyzed by one-way analysis of variance (ANOVA) and Fishers test.
Results
The number of resorbed fetuses, fetal weight and crown-rump length are presented in Table 1.
|
Table 1. Effect of different doses of an aqueous extract of Carthamus tinctorius given by intraperitoneal injection during the organogenic period in pregnant mice on the number of resorbed fetuses and the weight and length of embryos. |
|||||
|
Time of administration |
Dose (mg/kg) |
No. of fetuses |
No. of resorbed fetuses |
Weight (mean ± SD; g) |
Length (mean ± SD; mm) |
|
Control |
0 |
82 |
4 |
1.36 ± 0.20 |
21.76 ± 1.56 |
|
Day 7 |
50 |
25 |
16 |
0.87 ± 0.20* |
18.11 ± 1.81* |
|
Day 7 |
25 |
22 |
8 |
1.01 ± 0.14* |
19.31 ± 1.03* |
|
Day 7 |
10 |
50 |
12 |
1.12 ± 0.16* |
20.20 ± 1.45* |
|
Day 7 |
1 |
38 |
3 |
1.23 ± 0.13* |
21.32 ± 1.04 |
|
Day 8 |
50 |
23 |
12 |
0.80 ± 0.18* |
18.54 ± 2.21* |
|
Day 8 |
25 |
24 |
8 |
1.05 ± 0.12* |
19.96 ± 0.97* |
|
Day 8 |
10 |
43 |
10 |
1.11 ± 0.19* |
20.29 ± 1.22* |
|
Day 8 |
1 |
33 |
0 |
1.24 ± 0.08* |
21.51 ± 0.75 |
|
Day 9 and 10 |
50 |
23 |
23 |
|
|
|
Day 9 and 10 |
25 |
23 |
15 |
0.90 ± 0.09* |
18.63 ± 0.89* |
|
Day 9 and 10 |
10 |
38 |
13 |
1.02 ± 0.11* |
19.27 ± 1.18* |
|
Day 9 and 10 |
1 |
41 |
0 |
1.24 ± 0.14* |
21.83 ± 1.45 |
|
The results of ANOVA were as follow: p < 0.05, compared with control group; F-ratio = 25.34; DF = 340 (weight), F-ratio = 20.92; DF = 340 (length). *Significantly different from control group. |
|||||
The most effective dose produced the most resorbed fetuses and greatest loss of weight and length, which were significantly different from those in the control group (ANOVA, p < 0.05). There was no significant length reduction at the minimum dose (ANOVA, p < 0.05). A dose of 50 mg/kg was toxic and caused 50 100% resorption of fetuses and 30 60% mortality. The incidence of external malformations increased significantly with inceaseing dose (Table 2) (Fishers exact test, p < 0.02). Various external malformations, such as exencephaly, spina bifida and dermatological malformations, were observed in groups treated with doses of 50, 25 and 10 mg/kg on Days 7 and 8. The minimum dose (1 mg/kg) on Day 8 did not cause any external malformation, but on Days 7, 9 and 10, there were a few external malformations; feet and hand necrosis was seen in one case. There was evidence of hemorrhage on the skin of fetuses and also signs of echymosis, wrinkling and ichthyosis. The distal ends of limbs and the tails of embryos showed signs of ischemia and necrosis. Ocular defects, such as cataract and Peters anomaly (keratolenticular adhesion), were seen in some embryos. The aqueous extract of C. tinctorius flowers given to pregnant mice throughout the organogenic period caused abortion or death of dams at higher doses. At doses of 10 and 1 mg/kg, there was no bleeding or death of pregnant mice (Table 3).
|
Table 2. Incidence of external malformations in the fetuses of mice given different doses of aqueous extract of Carthamus tinctorius by intraperitoneal injection during the organogenic period. |
||||||||||
|
Time of administration |
Dose (mg/kg) |
No. of fetuses |
Surviving fetuses |
Excencephaly |
Spina bifida |
Dermatological manifestations§ |
||||
|
No. |
% |
No. |
% |
No. |
% |
No. |
% |
|||
|
Control |
0 |
82 |
78 |
95.1 |
|
|
|
|
|
|
|
Day 7 |
50 |
25 |
9 |
36.0 |
7 |
77.9 |
8 |
88.9 |
4 |
44.5 |
|
Day 7 |
25 |
22 |
14 |
63.6 |
5 |
35.7 |
4 |
28.6 |
3 |
21.4 |
|
Day 7 |
10 |
50 |
38 |
76 |
6 |
15.8 |
5 |
13.2 |
5 |
13.6 |
|
Day 7 |
1 |
38 |
35 |
92.1 |
0 |
0 |
1 |
2.9 |
1 |
2.9 |
|
Day 8 |
50 |
23 |
11 |
47.8 |
4 |
36.4 |
6 |
54.6 |
4 |
36.4 |
|
Day 8 |
25 |
24 |
16 |
66.7 |
3 |
18.8 |
3 |
18.8 |
3 |
18.8 |
|
Day 8 |
10 |
43 |
33 |
76.7 |
3 |
9.1 |
4 |
12.1 |
4 |
12.1 |
|
Day 8 |
1 |
33 |
33 |
100 |
|
|
|
|
|
|
|
Day 9 & 10 |
50 |
23 |
0 |
0 |
|
|
|
|
|
|
|
Day 9 & 10 |
25 |
23 |
8 |
34.8 |
|
|
3 |
37.5 |
2 |
25 |
|
Day 9 & 10 |
10 |
38 |
25 |
65.8 |
|
|
3 |
12 |
4 |
16 |
|
Day 9 & 10 |
1 |
41 |
41 |
100 |
|
|
|
|
1 |
2.4 |
|
* Fishers exact test; p < 0.02, compared with control group. All fetuses of dams that received 50 mg/kg on Days 9 and 10 were resorbed. Exencephaly observed in all groups except those that received injections on Days 9 and 10 (p < 0.02); All groups significantly different from control group except those that received 1 mg/kg on Day 7 (p < 0.02); § All groups significantly different from control group except those that received 1 mg/kg (p < 0.02). |
||||||||||
|
Table 3. Effect of different doses of aqueous extract of Carmathus tinctorius given by intraperitoneal injection during the organogenic period on the number of deaths and vaginal bleeding in dams. |
||||||
|
Time of administration |
Dose (mg/kg) |
No. of mice |
Bleeding |
Death of dams |
||
|
No. |
% |
No. |
% |
|||
|
Control |
0 |
10 |
0 |
0 |
0 |
0 |
|
Day 7 |
50 |
10 |
7 |
70 |
3 |
30 |
|
Day 7 |
25 |
10 |
5 |
50 |
2 |
20 |
|
Day 7 |
10 |
5 |
0 |
0 |
0 |
0 |
|
Day 7 |
1 |
5 |
0 |
0 |
0 |
0 |
|
Day 8 |
50 |
10 |
6 |
60 |
4 |
40 |
|
Day 8 |
25 |
10 |
4 |
40 |
1 |
10 |
|
Day 8 |
10 |
5 |
0 |
0 |
0 |
0 |
|
Day 8 |
1 |
5 |
0 |
0 |
0 |
0 |
|
Day 9 and 10 |
50 |
10 |
7 |
70 |
6 |
60 |
|
Day 9 and 10 |
25 |
10 |
6 |
60 |
3 |
30 |
|
Day 9 and 10 |
10 |
5 |
0 |
0 |
0 |
0 |
|
Day 9 and 10 |
1 |
5 |
0 |
0 |
0 |
0 |
Discussion
Many Compositae plants have a folk use as an abortion promoter. The water extract of C. tinctorius is used not only in medicine but also as a food colorant and flavoring. In our study, the number of absorbed fetuses and the percentage of post-implantation loss were dose dependent. These results indicate that the doses used in our study have some lethal effects. They also show that the doses used in pregnancy are important for reproductive performance.
Our purpose was to determine whether there was a correlation between the use of Carthamus extract and the occurrence of abortion or malformation at the doses of flower extract used in folk medicine. Thus, the doses of flower extract used varied from a minimum dose to a maximum dose that could cause abortion or toxicity in dams. This corresponded to doses of 1 mg/kg and 50 mg/kg on different days of the organogenic period. In a previous study, Nobakht et al showed that at doses of 1.6 and 2 mg/kg/day (12.8 mg 16 mg total), embryos were absorbed, while at lower doses (1.2 mg/kg/day, 9.6 mg total), changes in cellular orientation and degeneration were observed.7 In this study, we used a single IP dose of C. tinctorius flower extract to compare its effect on different days (7, 8, 9 and 10) of organogenesis. A dose of 50 mg/kg on Days 9 and 10 caused 100% absorption of fetuses and was also toxic for dams. A dose of 10 mg/kg on all days of administration caused no bleeding in dams but did cause absorption, weight and length lose, and exencephaly, spina bifida and dermatological manifestations. Exencephaly was not observed after treatment on Days 9 and 10, possibly because the nervous tube is formed on Days 7 and 8 and is complete by Day 9. One case, which received 1 mg/kg on Day 8 had embryos with no tail, which confirms the mutagenic effects of C. tinctorius flower extract published by others.4, 5 Overall, our results show that C. tinctorius flower extract could cause serious teratogenic effects on mice embryos . As a result, women who are pregnant or who might become so should carefully control their intake of Carthamus flowers (Golrang, safflower), both as an alternative medicine and as a food additive.
Acknowledgment
This work was supported by a grant from Shiraz University of Medical Sciences.
References
DerMarderosian A. The Review of Natural Products. 1st ed. Missouri: Facts and Comparisons; 2001.
Amin GH. Popular Medicinal Plants of Iran. Tehran: Health Ministry Press; 1991: 118 9.
Zargari A. Medicinal Plants. Tehran: University of Tehran Press, 1992: 33 4.
Morimoto I, Watanabe F, Osawa T. Mutagenicity screening of crude drugs with Bacillus subtilis rec-assay and Salmonella/microsome reversion assay. Mutat Res. 1982; 97: 81 102.
Yin XJ, Liu D, Wang H. A study on the mutagenicity of 102 raw pharmaceuticals used in Chinese traditional medicine. Mutat Res. 1991; 260: 73 82.
Yasukawa K, Akihisa T, Kaminaga T. Inhibitory effect of alkane-6,8-diols, the components of safflower, on tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Oncology. 1996; 53: 133 6.
Nobakht M, Fattahi M, Hormand M, et al . A study on the teratogenic and cytotoxic effects of safflower extract. J Ethnopharmacol. 2000; 73: 453 9.